17 trials tracked for Carpal Tunnel Syndrome: 3 in phase 3 or 4 and 1 with published results. The most-cited published study has 139 citations.
Showing the 17 most-cited and recently-updated of 17 trials. Browse the full registry →
Trial data sourced from ClinicalTrials.gov. Counts describe the research landscape and are not a treatment recommendation. Informational only — not medical advice.
Gabapentine was shown to significantly reduce chronic pain in patients with Carpal Tunnel Syndrome (p<0.05) 3.
While ultrasound has been utilized as an intervention or diagnostic tool in established protocols, clinical trials did not report statistically significant improvements in symptom severity (p=0.442), pain scores (p=0.083), or functional status (p=0.125) [11, 13].
Administration of Methylprednisolone 80 mg was evaluated for its impact on symptom severity, palmar pain, and DASH scores 1.
AI synthesis of 4 cited trials, updated Jun 24, 2026. Informational only — not medical advice; trial data sourced from ClinicalTrials.gov. How we use AI.
